COVID-19 Clinical Trials

A listing of COVID-19 medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 378 clinical trials
Motivation, Syringe Exchange, and COVID-19

People who inject drugs (PWIDs) are highly vulnerable to SARS-CoV-2 infection and to the disease caused by SARS-CoV-2, coronavirus disease 2019 (COVID-19), however, rates of SARS-CoV-2 testing

Accepts healthy volunteers
  • 0 views
  • 07 Oct, 2022
  • 1 location
COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)

To evaluate if omalizumab is effective in decreasing mortality in severe hospitalized COVID-19 cases.

  • 0 views
  • 04 Oct, 2022
  • 3 locations
Hyperpolarized 129Xe MRI of Survivors of COVID-19

The purpose of this study is to evaluate pulmonary function of patients recovering from mild, moderate, and severe COVID-19 disease using hyperpolarized 129Xe MRI.

  • 12 views
  • 07 Oct, 2022
  • 1 location
Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia

Of the many treatments proposed for COVID-19, few directly address the severe hypoxia among COVID-19 patients. Interim results from our single-center, non-randomized clinical trial (NCT04332081

  • 0 views
  • 04 Oct, 2022
  • 3 locations
T CELL THERAPY OPPOSING NOVEL COVID-19 INFECTION IN IMMUNOCOMPROMISED PATIENTS (TONI)

This is an open label, phase I dose-escalation study to evaluate the safety of coronavirus-specific T cell (CST) therapy for prevention of SARS-CoV-2 infection in immunocompromised patients following hematopoietic stem cell transplantation (HSCT). Participants will receive donor-derived CSTs for prevention of SARS-CoV-2 infection after HSCT (≥28 days and <4 months …

  • 0 views
  • 07 Oct, 2022
  • 2 locations
Temelimab as a Disease Modifying Therapy in Patients With Neurological, Neuropsychological, and Psychiatric (=Neuropsychiatric) Symptoms in Post-COVID 19 or Postacute Sequelae of COVID-19 (PASC) Syndrome

This study is a Phase 2, 24-week, randomized, prospective, double-blind, multicenter study in patients experiencing neuropsychiatric symptoms and functional impairment in the course of PASC. The purpose of the study is to evaluate the efficacy and safety of Temelimab as a treatment for PASC neuropsychiatric symptoms in patients who had …

  • 0 views
  • 24 Oct, 2022
  • 2 locations
Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Intervention

Post-Acute COVID-19 Syndrome (PACS) is a prevalent phenomenon that affects thousands of Veterans in VA care. VA patients suffering from PACS not only experience lingering physical symptoms

  • 0 views
  • 23 Oct, 2022
  • 1 location
Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

healthy adults for the prevention of COVID-19.

Accepts healthy volunteers
  • 22 views
  • 04 Oct, 2022
  • 2 locations
A Live Recombinant Newcastle Disease Virus-vectored COVID-19 Vaccine Phase 1 Study.

investigational product for IN, IM, or a combined IN+IM vaccination in healthy adults previously immunized against COVID-19. The IN and IM live virus vaccinations will be identical in composition and only differ

Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

This is a Phase II multi-center, double-blind, placebo-controlled, randomized study in Patients with moderate to severe lung injury due to COVID-19 or other potential viral and bacterial

  • 1 views
  • 04 Oct, 2022
  • 2 locations